Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6404-0.5246 (-45.03%)
At close: 04:00PM EDT
0.6285 -0.01 (-1.86%)
After hours: 07:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
5,746
4,101
749
0
0
Cost of Revenue
11,084
10,718
282
-
-
Gross Profit
-5,338
-6,617
467
-
-
Operating Expenses
Research Development
5,380
6,246
13,500
9,858
9,777
Selling General and Administrative
59,638
58,142
36,020
9,000
8,739
Total Operating Expenses
65,018
64,388
49,520
18,858
18,516
Operating Income or Loss
-70,356
-71,005
-49,053
-18,858
-18,516
Interest Expense
3,864
3,914
3,109
0
1,116
Total Other Income/Expenses Net
-
-
-
-
-990
Income Before Tax
-74,210
-74,894
-51,853
-18,606
-20,256
Income Tax Expense
-
-
0
0
-477
Income from Continuing Operations
-69,535
-74,894
-51,853
-18,606
-19,779
Net Income
-69,535
-74,894
-51,853
-18,606
-19,779
Net Income available to common shareholders
-69,535
-74,894
-51,853
-18,606
-19,779
Basic EPS
-
-30.80
-24.40
-15.20
-23.20
Diluted EPS
-
-30.80
-24.40
-15.20
-23.20
Basic Average Shares
-
2,427
2,117
1,236
857.898
Diluted Average Shares
-
2,427
2,117
1,236
857.898
EBITDA
-
-68,757
-48,468
-18,443
-19,117